Goldman Sachs Initiates Coverage On LifeStance Health Gr with Neutral Rating, Announces Price Target of $9
Benzinga Newsdesk 4 months ago
NewsPrice TargetInitiationAnalyst Ratings
Goldman Sachs analyst Scott Fidel initiates coverage on LifeStance Health Gr (NASDAQ:LFST) with a Neutral rating and announces Price Target of $9.
Goldman Sachs analyst Scott Fidel initiates coverage on LifeStance Health Gr (NASDAQ:LFST) with a Neutral rating and announces Price Target of $9.